Geode Capital Management »

Bolt Biotherapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $99k 19k 5.32
2025-06-30 $108k 19k 5.83

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Inc-class A Shares Com Cl A (V)
Netflix (NFLX)
Mastercard Inc - A Cl A (MA)

View all positions for Geode Capital Management

Top funds holding Bolt Biotherapeutics

Vivo Capital
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Tang Capital Management
Nan Fung Group Holdings
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Vanguard Group
Pfizer
Renaissance Technologies
Geode Capital Management
Susquehanna International
Shay Capital
Squarepoint Ops
DRW Holdings

View all funds holding Bolt Biotherapeutics